Diabetes

First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetes

Posted on: May 14, 2022   |   Posted by: Health Mag

First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetes

The FDA approved first-in-class tirzepatide for patients with type 2 diabetes, the agency announced on Friday. Tirzepatide, a glucagon-like peptide-1 and glucose-dependent...

Continue reading ...